This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

With Elan Deal, Perrigo Joins Long List of U.S. Corporate Tax Avoiders

Stocks in this article: PRGO ELN AMGN LLY AAPL

ALLEGAN, Mich. (But not for long) ( TheStreet) -- The roots of Perrigo (PRGO - Get Report) go back 126 years. Luther Perrigo, the proprietor of a general store and apple-drying business in western Michigan, had an idea to distribute medicines and other household goods to country stores. From these humble roots, Perrigo grew into a multi-billion dollar business selling over-the-counter and generic medicines, baby formula and nutritional supplements.

Perrigo was an American business success story. That ended Monday, when the company decided to buy Irish drug maker Elan (ELN) for $8.6 billion in order to evade... um, sorry, I mean reduce... its obligation to pay U.S. taxes.

The "new" Perrigo will no longer be headquartered in Allegan, Michigan, home of the "Old Iron Bridge." The company is moving to Dublin, Ireland where Elan is headquartered and companies pay only 12.5 percent corporate income tax.

Of course, Perrigo is not physically moving to Ireland. CEO Joseph Papa and his executives aren't selling their big houses in Michigan -- watched over by cops and firemen paid for with public funding. Their kids will continue to attend school here -- some may even go to U.S. taxpayer-funded public schools! The company's trucks will drive on roads built and maintained by U.S taxpayers.

The only part of Perrigo actually moving to Ireland is its bank account. Last year, Perrigo's effective tax rate was 23 percent. That's not low enough, apparently, so Papa bought Elan and is moving the corporate books to Dublin.

Perrigo is not alone in abandoning the U.S. for an overseas tax haven. Lots of companies are doing it. Apple (AAPL - Get Report) is probably the most famous U.S. income tax avoider, but in healthcare, Pfizer (PFE), Amgen (AMGN - Get Report) and Eli Lilly (LLY - Get Report) have all moved huge chunks of their business to tax-friendly locales.

Perrigo wins, America loses.

--Written by Adam Feuerstein in Boston.



>To contact the writer of this article, click here: Adam Feuerstein.

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs